Efficacy and safety of rucaparib in previously treated, locally advanced or metastatic urothelial carcinoma from a phase 2, open-label trial (ATLAS).
Grivas P, Loriot Y, Morales-Barrera R, Teo MY, Zakharia Y, Feyerabend S, Vogelzang NJ, Grande E, Adra N, Alva A, Necchi A, Rodriguez-Vida A, Gupta S, Josephs DH, Srinivas S, Wride K, Thomas D, Simmons A, Loehr A, Dusek RL, Nepert D, Chowdhury S.
Grivas P, et al. Among authors: dusek rl.
BMC Cancer. 2021 May 24;21(1):593. doi: 10.1186/s12885-021-08085-z.
BMC Cancer. 2021.
PMID: 34030643
Free PMC article.
Clinical Trial.